Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Methylthiouracil (NSC-193526) is a thiourea antithyroid agent that inhibits the synthesis of thyroid hormone, and it is used to treat hyperthyroidism.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | In stock | $ 40.00 | |
50 mg | In stock | $ 50.00 | |
100 mg | In stock | $ 74.00 | |
200 mg | In stock | $ 129.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 50.00 |
Description | Methylthiouracil (NSC-193526) is a thiourea antithyroid agent that inhibits the synthesis of thyroid hormone, and it is used to treat hyperthyroidism. |
In vitro | Methylthiouracil acts to decrease the formation of stored thyroid hormone, as thyroglobulin in the thyroid gland. Methylthiouracil is also used in combination with radioactive iodine. |
Synonyms | NSC-193526, NSC-9378, MTU |
Molecular Weight | 142.18 |
Formula | C5H6N2OS |
CAS No. | 56-04-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Ethanol: < 1 mg/mL (insoluble or slightly soluble)
DMSO: 27 mg/mL (189.9 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Methylthiouracil 56-04-2 Apoptosis Immunology/Inflammation MAPK NF-Κb Interleukin Antiviral TNF NF-κB ERK NSC 9378 Extracellular signal regulated kinases Nuclear factor-κB inhibit Tumor Necrosis Factor Receptor Inhibitor NSC193526 NSC9378 TNFR TNF Receptor Nuclear factor-kappaB Interleukin Related NSC 193526 NSC-193526 NSC-9378 MTU inhibitor